Bioequivalence of tegomil fumarate gastro-resistant capsules versus dimethyl fumarate gastro-resistant capsules under different fed conditions: two randomized, crossover, phase I studies.

Zietz K, Savu SR, Remis L, Nicolau N, Iordachescu A, Herb F

Open source

DOI
10.3389/fneur.2026.1936043
Published
2026
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1936043,
  title = {Bioequivalence of tegomil fumarate gastro-resistant capsules versus dimethyl fumarate gastro-resistant capsules under different fed conditions: two randomized, crossover, phase I studies.},
  author = {Zietz K and Savu SR and Remis L and Nicolau N and Iordachescu A and Herb F},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1936043},
  url = {https://doi.org/10.3389/fneur.2026.1936043}
}

RIS

TY  - JOUR
TI  - Bioequivalence of tegomil fumarate gastro-resistant capsules versus dimethyl fumarate gastro-resistant capsules under different fed conditions: two randomized, crossover, phase I studies.
AU  - Zietz K
AU  - Savu SR
AU  - Remis L
AU  - Nicolau N
AU  - Iordachescu A
AU  - Herb F
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1936043
UR  - https://doi.org/10.3389/fneur.2026.1936043
ER  - 

APA

K, Z., SR, S., L, R., N, N., A, I., & F, H. (2026). Bioequivalence of tegomil fumarate gastro-resistant capsules versus dimethyl fumarate gastro-resistant capsules under different fed conditions: two randomized, crossover, phase I studies.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1936043

Source records